Herpes is not included in most standard STD panels. When you go to a clinic and ask for “the full test” or a “standard STD screening,” you will typically be tested for chlamydia, gonorrhea, syphilis, and HIV. Herpes simplex virus, both type 1 and type 2, is deliberately left off that list in most clinical settings. This surprises many people, especially because herpes is extremely common. The reasons behind the exclusion involve test accuracy, official screening guidelines, and a calculation about whether the results cause more harm than good.
Why Herpes Is Left Off the Standard Panel
The U.S. Preventive Services Task Force, which sets the recommendations that most American clinics follow, explicitly recommends against routine blood testing for herpes in people without symptoms. Their reasoning, published in a 2016 recommendation statement, is blunt: the harms of screening outweigh the benefits for asymptomatic adolescents and adults, including pregnant individuals.1JAMA. Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement That is a strong statement from a body that rarely uses such definitive language. They are not saying the evidence is unclear; they are saying that screening asymptomatic people does more harm than good.
The “harm” side of that equation has two components. The first is the poor accuracy of available blood tests when used on people who have no symptoms. The second is the psychological impact of receiving a positive result for a lifelong infection, particularly when that result may be wrong. Both deserve a closer look.
The False Positive Problem With Blood Tests
If you do not have an active sore or blister, the only way to test for herpes is through a blood test that looks for antibodies your immune system produces in response to the virus. These serological tests can distinguish between HSV-1 (the type more commonly associated with oral cold sores) and HSV-2 (more commonly associated with genital herpes), which is useful. But their accuracy has serious limitations, especially when results fall in the low-positive range.
A 2024 study evaluating automated HSV antibody testing found that among samples with low-positive index values (below 3.0), the false positive rate was striking. For HSV-1, roughly 61% of low-positive results were false positives. For HSV-2, about 21% of low-positive results were false positives.2PubMed Central. Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing In practical terms, if your blood test comes back with a weakly positive number, there is a real chance you do not actually have the virus. For HSV-1 in particular, the odds are worse than a coin flip.
This matters because most people who get screened for herpes have no symptoms. They are the exact population where low-positive results are most common and most misleading. The test performs better in people who already have symptoms or a clinical history of herpes, because a higher antibody level tends to produce a more definitive result. But the whole point of screening is to catch the people who do not know they are infected, and that is precisely the group where the test is weakest.
What Happens When a Low-Positive Comes Back
An older study looking at men who tested positive for HSV-2 on a widely used ELISA blood test found that 84% of those results were confirmed by Western blot, which is considered the gold standard for serological confirmation. That sounds decent until you realize it means about 16% of positives were wrong. When the analysis was limited to men who also carried HSV-1 antibodies, confirmation dropped to 76%. Raising the threshold for calling a result positive from the standard cutoff to an index value of 3.0 or higher pushed the accuracy above 93%.3Sexually Transmitted Diseases. Herpes Simplex Virus Type 2 (HSV-2) Western Blot Confirmatory Testing Among Men Testing Positive for HSV-2 Using the Focus Enzyme-Linked Immunosorbent Assay in a Sexually Transmitted Disease Clinic
Western blot testing is the most reliable way to confirm a herpes antibody result, but it is expensive, not widely available, and not offered at most standard labs. Many clinics do not even mention it. So a person who gets a low-positive HSV-2 result may be told they have genital herpes when they may not, with no easy path to confirmation. The psychological weight of that diagnosis can be substantial, particularly because herpes carries more social stigma than its actual medical severity warrants. A systematic review examining the psychosocial impact of HSV-2 serological testing in people without a history of genital herpes found this concern to be a specific reason behind the recommendation against routine screening.4Sexually Transmitted Infections. Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review
When Testing for Herpes Does Make Sense
The recommendation against routine screening does not mean you should never be tested. There are clear situations where herpes testing is warranted and useful. If you have a visible sore, blister, or ulcer in the genital or oral area, a direct test of that lesion is the most accurate diagnostic approach. If you have a partner with known herpes and want to understand your own status, type-specific serology (a blood test based on a protein called glycoprotein G) can be informative, especially if the index value is clearly positive rather than hovering in the low-positive range.5BioMed Central / Virology Journal. Diagnosis of genital herpes simplex virus infection in the clinical laboratory If you have recurrent symptoms that have not been diagnosed, testing helps. And in pregnancy, where neonatal herpes is a serious concern, testing may be recommended in specific clinical scenarios.
The key distinction is between screening (testing everyone, regardless of symptoms or risk) and diagnostic testing (testing someone because there is a clinical reason to look). The medical community supports the second while discouraging the first.
Swab Tests Are More Accurate Than Blood Tests
If you have an active outbreak with visible lesions, a swab test is far more reliable than a blood test. The preferred method today is PCR, a molecular technique that detects the virus’s genetic material directly from a lesion swab. PCR consistently outperforms older methods like viral culture, which was the standard for decades but misses a significant number of infections.
A comparison study found that PCR detected herpes from swab specimens with 100% sensitivity, while culture detected only 50% of confirmed cases.6PubMed Central. Comparison of Herpes Simplex Virus PCR with Culture for Virus Detection in Multisource Surface Swab Specimens from Neonates Another study comparing multiple detection methods found that PCR-based approaches detected roughly 95 to 98% of true positives, while culture and older immunofluorescence techniques caught 86 to 88%.7PubMed Central. Comparison of Simplexa HSV 1 & 2 PCR with culture, immunofluorescence, and laboratory-developed TaqMan PCR for detection of herpes simplex virus in swab specimens PCR also produces results faster and can tell you whether the infection is HSV-1 or HSV-2, which affects long-term recurrence patterns and counseling.
The catch is that a swab test only works when there is something to swab. If you have no sores, there is nothing to test directly, which brings you back to the imperfect blood tests. And lesions that have already started to crust over or heal yield less virus, reducing the sensitivity of even PCR testing. The best time to swab is when a blister is fresh and unroofed.
The IgM Test Trap
Some clinics or online services offer an IgM blood test for herpes, which is marketed as a way to detect a “new” or “recent” infection. This test is widely considered unreliable by infectious disease specialists. IgM antibodies are the immune system’s first-wave response, and in theory they should spike during a brand-new infection and then fade. In practice, IgM antibodies to herpes can reappear during reactivation events (not just new infections), cross-react between HSV-1 and HSV-2, and produce false positives in people who do not have herpes at all.
If a provider orders an HSV IgM test for you, it is worth asking why and whether an IgG-based type-specific test would be more appropriate. IgG antibodies take longer to develop after initial infection, typically several weeks to a few months, but they are more specific and more useful for determining your actual HSV status. Early use of antiviral medications can delay or even prevent the development of these antibodies, which is worth knowing if you were treated empirically for a suspected first outbreak and then tried to confirm with a blood test shortly afterward.8PubMed Central. Laboratory techniques in the diagnosis of herpes simplex infection
Most Transmission Happens Without Visible Symptoms
One reason the herpes testing debate matters is that the virus spreads efficiently even when no one can see anything wrong. HSV-2 is periodically shed from genital skin and mucous membranes without producing visible lesions, and most sexual transmissions happen during these asymptomatic shedding episodes.9PubMed Central. Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding Many shedding episodes that lead to transmission involve ulcers so small they never reach the threshold of clinical detection.
A study tracking genital shedding in people with confirmed HSV-2 found that even among those who had never experienced a recognized outbreak, subclinical shedding occurred on roughly 9% of days sampled. Among those with symptomatic infections, that figure was around 13%.10PubMed Central. Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons with HSV-2 Infection This creates a paradox in the screening debate: the very people most likely to unknowingly transmit the virus are the ones the current guidelines say should not be routinely tested.
The counterargument from screening proponents is straightforward. If people knew their status, they could take precautions, use antivirals to reduce shedding, and disclose to partners. The counterargument from the USPSTF is equally direct: the available blood tests are not accurate enough in this group to justify the false positives, and there is limited evidence that knowing one’s status through screening actually changes transmission rates at a population level.
Herpes Does Not Always Look Like Herpes
Another complication is that genital herpes does not always present as the textbook cluster of painful blisters. A case series documenting atypical presentations found HSV in patients whose symptoms included mucopurulent cervicitis (a cervical discharge that mimicked a different infection), hemorrhagic cystitis (bloody, painful urination resembling a bladder infection), recurrent urethritis, and lower back pain.11PubMed Central. Atypical genital herpes: report of five cases All were confirmed by PCR. These are the kind of presentations that get misdiagnosed or missed entirely, because neither the patient nor the clinician thinks to test for herpes when the symptoms do not match expectations.
This is especially relevant for people who have been told their STD panel was “all clear.” If herpes was never on the panel, and their symptoms were subtle or atypical, they may carry the virus for years without knowing. People with recurrent genital symptoms that do not respond to antibiotics for other infections should ask specifically about herpes testing.
Herpes Testing in Pregnancy
Neonatal herpes, while rare, is a serious condition that can cause lasting neurological damage or death. The risk is highest when a mother acquires a new herpes infection near the time of delivery, because she has not yet developed antibodies that can partially protect the baby. This makes the question of whether to screen pregnant people for herpes particularly charged.12PubMed Central. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention
Despite the stakes, routine antenatal herpes screening has not been adopted. A cost-effectiveness analysis found that screening all pregnant women for HSV-1 and HSV-2 antibodies would not be cost-effective.13PubMed. The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and -2 antibodies The false positive rate of available tests, combined with the low absolute incidence of neonatal herpes, means mass screening would create more confusion and unnecessary interventions than it would prevent infections. Current practice focuses on targeted approaches: identifying women with active lesions at delivery, asking about history of genital herpes, and recommending cesarean delivery when active genital lesions are present at the onset of labor.
There is a targeted scenario where serological testing in pregnancy is helpful. If a pregnant person’s partner has known genital herpes but they themselves have never had symptoms, type-specific serology can determine whether they are already infected (and thus at lower risk of a new, dangerous primary infection during pregnancy) or seronegative (and should take precautions to avoid acquiring the virus late in pregnancy).
At-Home and Online Testing Kits
The growth of direct-to-consumer STD testing has created a situation where people can order herpes blood tests online or through at-home collection kits without a clinician’s guidance. A survey of internet-based STI testing services identified dozens of websites offering self-collection kits for herpes and other infections.14BMJ Journals. Utilising the internet to test for sexually transmitted infections: results of a survey and accuracy testing These services can fill a gap for people who face barriers to in-person care or who want more control over their health information. But they also remove the clinical context that makes herpes test results interpretable.
A high-positive HSV-2 result from an online test is probably real and worth discussing with a provider. A low-positive result from the same test, without a clinician to explain what the index value means or to order confirmatory testing, can cause significant distress over what may be a false positive. If you use one of these services, pay attention to the specific index value reported with your result, not just the “positive” or “negative” label. Values well above the standard cutoff are far more reliable than those hovering just above it.
How to Actually Get Tested If You Want To Be
If you decide you want herpes testing despite it not being part of the standard panel, you will usually need to ask for it specifically. Most providers will order it if you request it, though some may counsel you about the limitations first. Here is what to know about your options:
- Type-specific IgG serology: A blood draw that looks for antibodies to HSV-1 and HSV-2 separately. Most useful when the index value is clearly positive (above 3.0 to 3.5). Low-positive results should be confirmed with a different test or retested after several weeks.
- PCR swab test: The best option if you have a visible sore. Highly sensitive and specific, gives a fast type-specific result. Useless without an active lesion.
- Western blot: The gold standard confirmatory blood test for ambiguous serological results. Available through the University of Washington’s clinical virology lab and a small number of other reference laboratories. Your provider may need to specifically arrange for this.
Avoid IgM-based blood tests, viral culture without PCR backup, and any test that does not distinguish between HSV-1 and HSV-2. A result that says “herpes positive” without specifying the type tells you almost nothing useful, because most adults have been exposed to HSV-1 through non-sexual contact at some point in their lives.
The Disconnect Between Prevalence and Testing
Herpes is one of the most common infections on the planet. A large majority of the global adult population carries HSV-1, and a substantial fraction carries HSV-2. Yet most carriers have never been diagnosed, because most infections produce mild or no recognized symptoms, and the infection is deliberately excluded from routine testing. A major factor in ongoing HSV transmission is that most carriers are unaware of their diagnosis.15PubMed Central. Clinical assessment of assays for diagnosis of herpes simplex infection
This creates a genuine tension in public health. The tools exist to identify most infected people, but those tools produce enough false positives in low-risk populations that routine use does more harm than good under current evidence. Better tests, particularly those with lower false positive rates in the low-positive range, could eventually shift the calculus. Until then, herpes occupies an unusual space: a very common, mostly manageable infection that the medical system has decided is better left unscreened in the general population, even as it continues to spread primarily through people who do not know they have it.